Above, left to right: Sally J. Schwarz, MS, RPH, BCNP, with guest lecturer Lale Kostakoglu, MD, MPH, in the MIR cyclotron facility.
Guest lecturer Lale Kostakoglu, MD, MPH, a professor of radiology at the Icahn School of Medicine at Mount Sinai in New York, presented “Evolutions in PET/CT-Based Response Evaluation in Lymphoma: What’s Next?” at the 31st annual Daniel R. Biello Memorial Lecture at Mallinckrodt Institute of Radiology on March 8, 2017.
Kostakoglu’s active research includes multiple multicenter PET/CT studies in oncology, particularly in defining the role of PET/CT as a response marker. In addition, she has been involved in oncological applications of positron emission tomography imaging.
“Dr. Kostakoglu has been engaged with national and international groups in the development of new response criteria for lymphomas that are heavily based on PET,” says Barry A. Siegel, MD, professor of radiology and medicine, and director of the Division of Nuclear Medicine with MIR. “It was very relevant to both radiology and oncology communities at Washington University to have an expert review of lymphoma response criteria and of response-adapted approaches to managing lymphoma patients.” Sally Schwarz, professor of radiology at MIR, gave Kostakoglu a tour of Mallinckrodt’s cyclotron facility during her visit. The cutting-edge facility includes two laboratories that produce PET radiopharmaceuticals used for clinical and PET imaging. A sought-after national and global lecturer, Kostakoglu’s ultimate goal is to develop management strategies integrating molecular imaging techniques to individualize cancer therapy by early assessment of chemosensitivity.